VS Digital Health for clinics: who actually buys and uses it

An owner should evaluate VSDH on total platform economics: annual white-label subscription, revenue share on transactions, and how wholesale catalog pricing translates to patient-program margin. Because landed cost is partner-agreement driven, confirm per-vial numbers on your top SKUs during sales — not from a public catalog. An operations lead should evaluate daily motion: ConnectRxCare order assembly time, mixed-supplier basket handling, rejection recovery, and whether batch refill day requires repeating the same fields patient by patient.

A prescriber should evaluate clinical coverage and submission accuracy: whether your team prescribes or VSDH's network does, whether documentation and standing orders meet your compliance bar, and how often clean orders fail downstream. Each role's risk differs, but they share one fork — full white-label stack versus clinic-first ordering when you already have patients and prescribers.

Fizy Health serves clinics that already prescribe and need pharmacy ops without re-platforming into a white-label consumer wrapper. The owner sees pass-through per-vial 503A cost on every catalog and cart line before checkout. The operations lead gets one clinic cart that batches every patient's order for refill day, with cart validation before payment. The prescriber gets SIG and licensure checks before submit, reducing post-pay rejections.

Same 503A fulfillment category — different primary motion. VSDH fits clinic operators building a new consumer brand; Fizy Health fits clinic operators optimizing refill-day economics on an existing prescriber panel. VSDH may still supply SKUs behind Fizy Health fulfillment; evaluate platform and supplier separately.